Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Content of the FHIR Service

Published:

Changes

The FHIR service publishes foundational medicinal data based on the FHIR-R4 standard. An upgrade to FHIR-R5 is planned as soon as the underlying service supports it. The FHIR service supports version management for planned updates to the data content over time. The service contains data about medicines available for sale in Norway, intended for human use. The volume of data will increase over time.

Current FHIR Service Includes

  • Medicinal Product: Contains information about trade names, approved medicinal forms, etc. (Medicinal Product).
  • Medicinal Product Package: Contains item numbers, marketing status, product codes, etc. (MedicinalProductPackaged).
  • Packaging Information in accordance with the ISO IDMP standard and product codes for external and internal packaging (available from 15.06.2025).
    • Description of the packaging/packaging size and structured breakdown of the various packaging levels, enabling product codes to be linked to the correct level.
    • Pharmaceutical suppliers report their products, with product codes following the GTIN standard, for marketing to Farmalogg. DMP's FHIR service retrieves product codes from Farmalogg.
  • Substance Registry with linkage to ATC codes (available from 15.06.2025).
    • Description of substances, including information about names, relevant IDs (SMS-ID, UniiCode), molecular weight, and classifications of substances.
    • The registry includes therapeutic and complete active substances.
    • Relationships between substances in the registry, with associated roles for the relationships.
  • Code system for medicinal forms in accordance with the IDMP standard (available from 15.06.2025).
    • DMP retrieves code systems from the SPOR database for code systems (Referentials). SPOR delivers code systems from EDQM.

Planned additions to the service by 2026

  • Manufactured Medicinal Product and Administrable Medicinal Productin accordance with the IDMP standard:
    • Information about manufactured medicinal products, including manufactured medicinal form and presentation unit.
    • Information about administrable medicinal products, including administrable medicinal form, presentation unit, and administration routes.
  • Active Substance and Strengthin accordance with the IDMP standard:
    • Information about active substances found in administrable/manufactured medicinal products, including the strength of the active substance.
    • Information about strength-defining substances (Basis of Strength Substance) and, where relevant, therapeutic components (Active Moiety), both with associated strengths.
  • Information about Nutritional Products:
    • Data on both parenteral and enteral nutritional products.
    • Information about nutritional products includes content such as nutrients, energy, known allergens, and flavor.
    • Information about nutritional products is retrieved from Farmalogg. For parenteral nutritional medicines, this information is compared and linked to data from DMP.
  • H-prescription:
    • Information about treatment groups for H-prescriptions. Each group consists of one or more ICD-10 codes along with a prioritized list of medicines available for prescribing H-prescription medicines.

 

The figure provides an overview of the FHIR resources to be delivered as part of the SAFEST project.

Figure 1: The figure provides an overview of the FHIR resources to be delivered as part of the SAFEST project.